You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Last Updated: October 1, 2023

Patent: 8,962,034

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 8,962,034
Title:Antiviral therapy with a whole, leech saliva extract
Abstract: Methods are provided for isolating and using a whole-saliva leech extract. The methods can include feeding a phagostimulatory agent to a leech; inducing a regurgitation in the leech, the inducing including placing the leech in an environment having a temperature of less than about C.; and, collecting an unrefined, whole saliva in the regurgitation of the cooled leech. The methods can include revitalizing the leech by warming it at a temperature ranging from about C. to about C. Stable, lyophilized, whole-saliva extracts of a leech are also provided, the extract having a stable activity when stored for use at a temperature below about C., the extract maintaining at least 70% of the activity for at least 6 months. The extracts can be used to treat solid tumors, treat liquid tumors, treat diabetes, treat a viral disease, treat a parasitic disease, treat an antibacterial disease, or serve as an anti-oxidant.
Inventor(s): Ghawi; Abbas Mohammad (Selangor, MY), Merzouk; Ahmed (Richmond, CA), Abdualkader; Abdualrahman (Pahang, MY), Alaama; Mohamed (Pahang, MY)
Assignee: Biopep Solutions, Inc. (Richmond, BC, CA)
Application Number:14/282,893
Patent Claims:see list of patent claims

Details for Patent 8,962,034

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Zr Pharma& Gmbh PEGASYS peginterferon alfa-2a Injection 103964 10/16/2002 ⤷  Try a Trial 2032-09-17
Zr Pharma& Gmbh PEGASYS peginterferon alfa-2a Injection 103964 01/07/2004 ⤷  Try a Trial 2032-09-17
Zr Pharma& Gmbh PEGASYS peginterferon alfa-2a Injection 103964 09/29/2011 ⤷  Try a Trial 2032-09-17
Hoffmann-la Roche Inc. PEGASYS COPEGUS COMBINATION PACK peginterferon alfa-2a and ribavirin 125083 06/04/2004 ⤷  Try a Trial 2032-09-17
Schering Corporation A Subsidiary Of Merck & Co., Inc. PEGINTRON/ REBETOL COMBO PACK peginterferon alfa-2b and ribavirin 125196 06/13/2008 ⤷  Try a Trial 2032-09-17
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.